BHVN logo

BHVN Cash From Financing

Annual CFF

$677.77 M
+$465.87 M+219.84%

December 31, 2024


Summary


Performance

BHVN Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBHVNcash flowmetrics:

Quarterly CFF

$272.85 M
+$192.48 M+239.47%

December 31, 2024


Summary


Performance

BHVN Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBHVNcash flowmetrics:

TTM CFF

$677.77 M
+$27.62 M+4.25%

December 31, 2024


Summary


Performance

BHVN TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBHVNcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

BHVN Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+219.8%+11.3%+219.8%
3 y3 years+389.6%-48.5%-11.7%
5 y5 years+56.0%-48.5%-11.7%

BHVN Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-11.7%+389.6%-48.5%+788.0%-12.1%+2842.6%
5 y5-year-11.7%+389.6%-48.5%+788.0%-14.1%+2842.6%
alltimeall time-11.7%>+9999.0%-48.5%+788.0%-14.1%>+9999.0%

Biohaven Pharmaceutical Holding Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2024
$677.77 M(+219.8%)
$272.85 M(+239.5%)
$677.77 M(+4.2%)
Sep 2024
-
$80.38 M(-75.0%)
$650.16 M(+22.6%)
Jun 2024
-
$321.12 M(+9281.3%)
$530.13 M(+181.0%)
Mar 2024
-
$3.42 M(-98.6%)
$188.66 M(-11.0%)
Dec 2023
$211.91 M(-72.4%)
$245.24 M(-718.4%)
$211.91 M(-57.3%)
Sep 2023
-
-$39.66 M(+95.0%)
$496.85 M(-25.2%)
Jun 2023
-
-$20.34 M(-176.3%)
$664.05 M(-13.9%)
Mar 2023
-
$26.67 M(-95.0%)
$771.23 M(+0.5%)
Dec 2022
$767.60 M(+454.4%)
$530.18 M(+315.7%)
$767.60 M(+223.3%)
Sep 2022
-
$127.54 M(+46.9%)
$237.42 M(+116.1%)
Jun 2022
-
$86.84 M(+277.0%)
$109.87 M(+377.0%)
Mar 2022
-
$23.03 M(+18.9%)
$23.03 M(-97.1%)
Dec 2021
$138.45 M(-9.1%)
-
-
Dec 2020
$152.24 M(-65.0%)
-
-
Dec 2020
-
$19.37 M(-95.9%)
$788.82 M(+2.2%)
Sep 2020
-
$472.31 M(+3988.9%)
$772.20 M(+139.8%)
Jun 2020
-
$11.55 M(-96.0%)
$322.05 M(-55.2%)
Mar 2020
-
$285.60 M(>+9900.0%)
$719.13 M(+65.5%)
Dec 2019
$434.59 M
-
-
DateAnnualQuarterlyTTM
Dec 2019
-
$2.75 M(-87.6%)
$434.59 M(-23.5%)
Sep 2019
-
$22.15 M(-94.6%)
$567.86 M(+3.9%)
Jun 2019
-
$408.63 M(>+9900.0%)
$546.31 M(+91.3%)
Mar 2019
-
$1.06 M(-99.2%)
$285.52 M(-16.1%)
Dec 2018
$340.46 M(+62.3%)
-
-
Dec 2018
-
$136.01 M(>+9900.0%)
$340.46 M(+66.2%)
Sep 2018
-
$602.00 K(-99.6%)
$204.85 M(+3.8%)
Jun 2018
-
$147.85 M(+164.0%)
$197.26 M(-13.4%)
Mar 2018
-
$56.00 M(>+9900.0%)
$227.81 M(+8.6%)
Dec 2017
$209.76 M(+283.0%)
-
-
Dec 2017
-
$397.00 K(-105.7%)
$209.76 M(-15.4%)
Sep 2017
-
-$6.99 M(-103.9%)
$247.96 M(-5.1%)
Jun 2017
-
$178.40 M(+370.1%)
$261.27 M(+191.2%)
Mar 2017
-
$37.95 M(-1.7%)
$89.73 M(+63.9%)
Dec 2016
$54.76 M(+930.1%)
-
-
Dec 2016
-
$38.60 M(+510.6%)
$54.76 M(+238.9%)
Sep 2016
-
$6.32 M(-7.8%)
$16.16 M(+64.3%)
Jun 2016
-
$6.86 M(+130.2%)
$9.84 M(+230.2%)
Mar 2016
-
$2.98 M
$2.98 M
Dec 2015
$5.32 M
-
-

FAQ

  • What is Biohaven Pharmaceutical Holding annual cash flow from financing activities?
  • What is the all time high annual CFF for Biohaven Pharmaceutical Holding?
  • What is Biohaven Pharmaceutical Holding annual CFF year-on-year change?
  • What is Biohaven Pharmaceutical Holding quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Biohaven Pharmaceutical Holding?
  • What is Biohaven Pharmaceutical Holding quarterly CFF year-on-year change?
  • What is Biohaven Pharmaceutical Holding TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Biohaven Pharmaceutical Holding?
  • What is Biohaven Pharmaceutical Holding TTM CFF year-on-year change?

What is Biohaven Pharmaceutical Holding annual cash flow from financing activities?

The current annual CFF of BHVN is $677.77 M

What is the all time high annual CFF for Biohaven Pharmaceutical Holding?

Biohaven Pharmaceutical Holding all-time high annual cash flow from financing activities is $767.60 M

What is Biohaven Pharmaceutical Holding annual CFF year-on-year change?

Over the past year, BHVN annual cash flow from financing activities has changed by +$465.87 M (+219.84%)

What is Biohaven Pharmaceutical Holding quarterly cash flow from financing activities?

The current quarterly CFF of BHVN is $272.85 M

What is the all time high quarterly CFF for Biohaven Pharmaceutical Holding?

Biohaven Pharmaceutical Holding all-time high quarterly cash flow from financing activities is $530.18 M

What is Biohaven Pharmaceutical Holding quarterly CFF year-on-year change?

Over the past year, BHVN quarterly cash flow from financing activities has changed by +$27.62 M (+11.26%)

What is Biohaven Pharmaceutical Holding TTM cash flow from financing activities?

The current TTM CFF of BHVN is $677.77 M

What is the all time high TTM CFF for Biohaven Pharmaceutical Holding?

Biohaven Pharmaceutical Holding all-time high TTM cash flow from financing activities is $788.82 M

What is Biohaven Pharmaceutical Holding TTM CFF year-on-year change?

Over the past year, BHVN TTM cash flow from financing activities has changed by +$465.87 M (+219.84%)